Constructing a Risk Prediction Model for Intraoperative Hypothermia in Children Under General Anesthesia
Launched by HARBIN MEDICAL UNIVERSITY · Mar 22, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The study first clarified the overall incidence and influencing factors of IOH in children through meta-analysis, combined with expert consultation to determine potential predictive variables, and developed a data questionnaire for this study. The second part of the study will collect data prospectively, use four algorithms in machine learning, including logistic regression, decision tree, random forest, and support vector machine, to build an excellent intraoperative hypothermia risk prediction model, and conduct internal verification of the model. The third part of the study prospectively...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \< 16 years old;
- • Anesthesia includes general anesthesia;
- • Anesthesia duration \> 30 minutes.
- Exclusion Criteria:
- • Cardiac surgery or other procedures that require lowering the child's body temperature;
- • Refusing to participate in this study;
- • ASA grade \>Ⅳ;
- • Abnormal basal body temperature, preoperative core body temperature \<36.0℃ or \>38.0℃;
- • Hyperthyroidism or hypothyroidism and other diseases that affect body temperature;
- • The core body temperature cannot be measured due to surgery or ear canal disease.
About Harbin Medical University
Harbin Medical University is a prominent research institution located in Harbin, China, dedicated to advancing healthcare through innovative medical education and clinical research. With a strong emphasis on interdisciplinary collaboration, the university fosters a rigorous academic environment that supports a diverse range of clinical trials aimed at improving patient outcomes and addressing pressing health challenges. Its commitment to scientific excellence and ethical standards positions Harbin Medical University as a key player in the global medical research landscape, contributing valuable insights and breakthroughs in various fields of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Harbin, Heilongjiang, China
Patients applied
Trial Officials
Huanglu Lan
Principal Investigator
The Sixth Affiliated Hospital of Harbin Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported